Zhejiang Hisun Pharmaceutical Co Ltd (600267) — Capital Reinvestment Ratio
Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥438.43 Million) in capital expenditures (CN¥102.69 Million). See net asset quality index of Zhejiang Hisun Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Hisun Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Zhejiang Hisun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 27 annual periods. Check 600267 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Hisun Pharmaceutical Co Ltd from 1999 to 2025. For live market cap and broader valuation context, see market value of Zhejiang Hisun Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | CN¥2.03 Billion | CN¥376.40 Million | ▲ +64.3% |
| 2024 | 0.11x | CN¥2.11 Billion | CN¥238.44 Million | ▼ -28.7% |
| 2023 | 0.16x | CN¥1.52 Billion | CN¥240.04 Million | ▼ -38.4% |
| 2022 | 0.26x | CN¥2.07 Billion | CN¥530.62 Million | ▼ -28.3% |
| 2021 | 0.36x | CN¥1.74 Billion | CN¥622.38 Million | ▼ -17.7% |
| 2020 | 0.44x | CN¥1.59 Billion | CN¥692.04 Million | ▼ -71.8% |
| 2019 | 1.54x | CN¥698.39 Million | CN¥1.08 Billion | ▲ +39.3% |
| 2018 | 1.11x | CN¥1.45 Billion | CN¥1.60 Billion | ▼ -6.1% |
| 2017 | 1.18x | CN¥1.24 Billion | CN¥1.46 Billion | ▼ -48.2% |
| 2016 | 2.28x | CN¥775.90 Million | CN¥1.77 Billion | ▼ -13.0% |
| 2015 | 2.62x | CN¥736.17 Million | CN¥1.93 Billion | ▼ -30.7% |
| 2014 | 3.78x | CN¥571.04 Million | CN¥2.16 Billion | ▼ -6.1% |
| 2013 | 4.02x | CN¥527.25 Million | CN¥2.12 Billion | ▼ -7.4% |
| 2012 | 4.34x | CN¥375.75 Million | CN¥1.63 Billion | ▲ +76.4% |
| 2011 | 2.46x | CN¥525.31 Million | CN¥1.29 Billion | ▲ +52.4% |
| 2010 | 1.62x | CN¥509.18 Million | CN¥823.08 Million | ▼ -11.3% |
| 2009 | 1.82x | CN¥472.85 Million | CN¥861.67 Million | ▼ -37.8% |
| 2008 | 2.93x | CN¥221.28 Million | CN¥648.25 Million | ▲ +309.2% |
| 2007 | 0.72x | CN¥437.72 Million | CN¥313.34 Million | ▼ -75.5% |
| 2006 | 2.92x | CN¥108.03 Million | CN¥315.67 Million | ▲ +23.4% |
| 2005 | 2.37x | CN¥113.53 Million | CN¥268.75 Million | ▲ +137.0% |
| 2004 | 1.00x | CN¥312.93 Million | CN¥312.52 Million | ▲ +13.5% |
| 2003 | 0.88x | CN¥288.45 Million | CN¥253.90 Million | ▼ -56.3% |
| 2002 | 2.01x | CN¥120.82 Million | CN¥243.39 Million | ▼ -47.5% |
| 2001 | 3.84x | CN¥69.14 Million | CN¥265.33 Million | ▲ +5.4% |
| 2000 | 3.64x | CN¥55.70 Million | CN¥202.76 Million | ▼ -0.3% |
| 1999 | 3.65x | CN¥32.64 Million | CN¥119.23 Million | — |